1. WHO Policy Perspectives on Medicines - The Selection of Essential Medicines. Geneva: World Health Organization; 2002. http://apps.who.int/medicinedocs/pdf/s2296e/s2296e.pdf . Accessed 13 Jan 2016.
2. Millar TP, Wong S, Odierna DH, Bero LA. Applying the essential medicines concept to US preferred drug lists. Am J Public Health. 2011;101(8):1444–8.
3. Equitable access to essential medicines: a framework for collective action. Geneva: World Health Organization; 2004. http://apps.who.int/iris/handle/10665/68571 . Accessed 5 April 2015.
4. Bazargani YT, Ewen M, De Boer A, Leufkens HGM, Mantel-Teeuwisse AK. Essential medicines are more available than other medicines around the globe. PLoS One. 2014;9:1–7.
5. Alpern JD, Stauffer WM, Kesselheim AS. High-cost generic drugs — implications for patients. N Engl J Med. 2014;371:1859–62.